Citation Tools

Download PDFPDF

Short report
ARID1A alterations function as a biomarker for longer progression-free survival after anti-PD-1/PD-L1 immunotherapy

Download to a citation manager

Cite this article as:
Okamura R, Kato S, Lee S, et al
ARID1A alterations function as a biomarker for longer progression-free survival after anti-PD-1/PD-L1 immunotherapy